Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India
暂无分享,去创建一个
[1] R. Bexiga,et al. Virulence Gene Pool Detected in Bovine Group C Streptococcus dysgalactiae subsp. dysgalactiae Isolates by Use of a Group A S. pyogenes Virulence Microarray , 2011, Journal of Clinical Microbiology.
[2] J. Thakur,et al. emm type distribution pattern of group A streptococcus in north India: need for a new preventive approach , 2010, The Indian journal of medical research.
[3] G. S. Chhatwal,et al. Contribution of Streptococcus anginosus to Infections Caused by Groups C and G Streptococci, Southern India , 2010, Emerging infectious diseases.
[4] M. P. van der Linden,et al. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. , 2010, FEMS immunology and medical microbiology.
[5] W. Argraves,et al. Serum Opacity Factor Is a Streptococcal Receptor for the Extracellular Matrix Protein Fibulin-1* , 2009, Journal of Biological Chemistry.
[6] J. Carapetis,et al. Superantigen genes in group A streptococcal isolates and their relationship with emm types. , 2008, Journal of medical microbiology.
[7] R. Kumar,et al. Comparative analysis of emm type pattern of Group A Streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factor , 2008, BMC Microbiology.
[8] B. Beall,et al. emm type diversity of beta-haemolytic streptococci recovered in Chennai, India. , 2008, Journal of medical microbiology.
[9] V. Nizet,et al. Opacity Factor Activity and Epithelial Cell Binding by the Serum Opacity Factor Protein of Streptococcus pyogenes Are Functionally Discrete* , 2008, Journal of Biological Chemistry.
[10] M. McDonald,et al. Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in Tropical Communities, Northern Australia , 2007, Emerging infectious diseases.
[11] Birgit Plümäkers,et al. A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity. , 2007, International journal of medical microbiology : IJMM.
[12] V. Nizet,et al. Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence , 2006, Molecular microbiology.
[13] J. Musser,et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. , 2005, The Journal of infectious diseases.
[14] R. Dal-Ré,et al. Survey of emm-Like Gene Sequences from Pharyngeal Isolates of Group C and Group G Streptococci Collected in Spain , 2005, Journal of Clinical Microbiology.
[15] Bernd Kreikemeyer,et al. Function of the Fibronectin-Binding Serum Opacity Factor of Streptococcus pyogenes in Adherence to Epithelial Cells , 2004, Infection and Immunity.
[16] M. Farley,et al. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. , 2003, FEMS microbiology letters.
[17] A. Bisno,et al. Molecular basis of group A streptococcal virulence. , 2003, The Lancet. Infectious diseases.
[18] T. Proft,et al. Two Novel Superantigens Found in Both Group A and Group C Streptococcus , 2003, Infection and Immunity.
[19] D. Bessen,et al. Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. , 2003, FEMS microbiology letters.
[20] T. Menon,et al. EMM types of Streptococcus pyogenes in Chennai. , 2001, Indian journal of medical microbiology.
[21] M. Rohde,et al. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population , 2000, The Lancet.
[22] M. Cunningham,et al. Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.
[23] Herbert C. Chiang,et al. Serum opacity factor is a major fibronectin‐binding protein and a virulence determinant of M type 2 Streptococcus pyogenes , 1999, Molecular microbiology.
[24] T. Proft,et al. Identification and Characterization of Novel Superantigens from Streptococcus pyogenes , 1999, The Journal of experimental medicine.
[25] Dwight R. Johnson. Laboratory Diagnosis of Group a Streptococcal Infections , 1997 .
[26] R. George,et al. Virulence regulon polymorphism in group A streptococci revealed by long PCR and implications for epidemiological and evolutionary studies. , 1996, Journal of medical microbiology.
[27] A. Podbielski,et al. M or M-like protein gene polymorphisms in human group G streptococci , 1995, Journal of clinical microbiology.
[28] A. Fox,et al. Role of beta-hemolytic group C streptococci in pharyngitis: incidence and biochemical characteristics of Streptococcus equisimilis and Streptococcus anginosus in patients and healthy controls , 1993, Journal of clinical microbiology.
[29] A. Fox,et al. Role of group C beta-hemolytic streptococci in pharyngitis: epidemiologic study of clinical features associated with isolation of group C streptococci , 1993, Journal of clinical microbiology.
[30] A. Denesyuk,et al. Protein V, a novel type-II IgG receptor from Streptococcus sp.: sequence, homologies and putative Fc-binding site. , 1992, Gene.
[31] A. Bisno,et al. Group G streptococcal M protein exhibits structural features analogous to those of class I M protein of group A streptococci , 1992, Infection and immunity.
[32] R. Lancefield,et al. THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN , 1935, The Journal of experimental medicine.
[33] W. Bahnan,et al. emm typing, antibiotic resistance and PFGE analysis of Streptococcus pyogenes in Lebanon. , 2011, Journal of medical microbiology.
[34] Naoko Chiba,et al. Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections. , 2010, Journal of medical microbiology.
[35] A. Podbielski,et al. Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci , 2004, Medical Microbiology and Immunology.
[36] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[37] P. Marrack,et al. Superantigens and their potential role in human disease. , 1993, Advances in immunology.
[38] H. Hammar,et al. Group G streptococcal infections on a dermatological ward. , 1992, Acta dermato-venereologica.